Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

A Phase Ib Open Label Study to assess the Safety and Pharmacokinetics of NUC-3373, a Nucleotide Analogue, given in Combination with Standard Agents used in Colorectal Cancer Treatment

Multiple Cancer Types

Colon, Phase I, Rectal
Ciombor, Kristen

To learn more about any of our clinical
trials, call 615-936-8422.